NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
2.200
+0.010 (0.46%)
At close: Jun 18, 2026, 4:00 PM EDT
2.247
+0.047 (2.14%)
After-hours: Jun 18, 2026, 6:45 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $233.65 million as of June 18, 2026. Its market cap has increased by 36.02% in one year.
Market Cap
233.65M
Enterprise Value
221.78M
1-Year Change
36.02%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $233.65M, an increase of 524.23%. That is a compound annual growth rate of 28.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 233.65M | -47.58% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 243.66M |
| Fate Therapeutics | 243.61M |
| Sol-Gel Technologies | 243.41M |
| Orchestra BioMed Holdings | 238.92M |
| AC Immune | 238.08M |
| Whitehawk Therapeutics | 237.72M |
| Canton Strategic Holdings | 233.85M |
| Cybin | 233.67M |